Curis inc news yahoo
WebNov 7, 2024 · Curis Inc (NASDAQ:CRIS), a biotechnology company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGM, rising to the highs of $2.16Read More... WebNov 9, 2024 · Curis , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.83 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 6.77% ...
Curis inc news yahoo
Did you know?
WebMar 14, 2024 · Curis reported a net loss of $56.7 million or $0.61 per share for the 12 months ended December 31, 2024, as compared to a net loss of $45.4 million or $0.50 per share for the same period in 2024. Revenues for the fourth quarter of 2024 and 2024 were $2.9 million and $3.1 million, respectively. WebMar 14, 2024 · As of December 31, 2024, Curis' cash, cash equivalents and investments totaled $85.6 million, and there were approximately 96.6 million shares of common stock outstanding. We continue to have a...
WebApr 10, 2024 · Curis, Inc. (CRIS) Stock Historical Prices & Data - Yahoo Finance U.S. markets close in 25 minutes S&P 500 4,092.44 -32.07(-0.78%) Dow 30 33,352.19 -248.96(-0.74%) Nasdaq 12,099.00... WebNov 9, 2024 · As at June 2024, Curis had cash of US$107m and no debt. Importantly, its cash burn was US$47m over the trailing twelve months. So it had a cash runway of about 2.3 years from June 2024. That's...
Web2 days ago · Legend Trading, a leading cryptocurrency trading firm with over 800 institutional clients, has launched Legend Pay, a fiat-to-crypto payment gateway that bridges the gap between traditional ... WebJun 4, 2024 · Is Curis, Inc. (NASDAQ: CRIS) a good investment now? The smart money is getting more optimistic. The number of long hedge fund bets increased by 1 in recent months. Our calculations also showed...
WebApr 11, 2024 · Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration ...
WebCuris (CRIS) Reports Q4 Loss, Misses Revenue Estimates Curis (CRIS) delivered earnings and revenue surprises of 14.29% and 4.72%, respectively, for the quarter ended … simutech solution corpWebNov 7, 2024 · Curis, Inc. to Host Earnings Call ACCESSWIRE November 7, 2024, 6:30 AM NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Curis, Inc. (NASDAQ: CRIS) will be discussing their earnings results... simutech troubleshooting garage doorWebAug 30, 2024 · Find the latest news headlines from Curis, Inc. Common Stock (CRIS) at Nasdaq.com. rcw injunctionWebMar 2, 2024 · Get the latest news and real-time alerts from Curis, Inc. (CRIS) stock at Seeking Alpha. rcw international building codeWebMar 13, 2024 · Zacks Equity Research. March 13, 2024, 6:15 AM · 3 min read. Curis (CRIS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares ... simutech ansys trainingWebJun 10, 2024 · Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the presentation of novel findings on ... simutech troubleshooting control circuitsWebApr 6, 2024 · A high-level overview of Curis, Inc. (CRIS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. rcw interfering with reporting